SANDIMMUN NEORAL caps 50 mg 50 pce

7680526560368 CH-52656 L04AD01 07.15.0.

Reimbursement limitations:

SANDIMMUN NE

Transplantations.
Maladies immunologiques graves ainsi que rares (aussi celles enregistrées sous Possibilité d'emploi), ne répondant …

SANDIMMUN NEORAL caps 50 mg 50 pce
SANDIMMUN NEORAL caps 50 mg 50 pce
SANDIMMUN NEORAL caps 50 mg 50 pce
1 / 3
google

Details

Product number
5265602
CPT
-
Packaging group
50
Unit
Kapsel(n)
Composition
ciclosporinum 50 mg, ethanolum anhydricum 50 mg, propylenglycolum 50 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 202.5 mg, E 307, Kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 40.36 mg, gelatina, Drucktinte: E 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % V/V.

Articles (1)

Sandimmun Neoral 50 mg, Kapseln
Kapseln
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
22/11/2023
Professional SmPC
Français
22/11/2023
Professional SmPC
Italien
22/11/2023
Patient information leaflet
Allemand
16/11/2023
Patient information leaflet
Français
16/11/2023
Patient information leaflet
Italien
16/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance HBESI
(N/A)
50.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
202.5 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
40.36 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 97.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1995

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
52656
Drug name
Sandimmun Neoral, Kapseln
Galenic form
KAPWE
ATC Code
L04AD01
Authorization status
Z
Dispensation category
B
First authorization
16/05/1994
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Packaging details

Description (FR)
SANDIMMUN NEORAL caps 50 mg 50 pce
Description (DE)
SANDIMMUN NEORAL Kaps 50 mg 50 Stk
Market launch
16/05/1994
Narcotic (BTM)
No

Other packaging sizes

SANDIMMUN NEORAL caps 25 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 100 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 10 mg 60 pce
60 KAP
View